ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+29.62%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$385M
AUM Growth
+$385M
(+49%)
Cap. Flow
+$80.5M
Cap. Flow
% of AUM
20.88%
Top 10 Holdings %
Top 10 Hldgs %
61.25%
Holding
32
New
6
Increased
12
Reduced
2
Closed
9
Top Buys
| 1 |
Hologic
HOLX
|
$28.5M |
| 2 |
Baxter International
BAX
|
$19.8M |
| 3 |
IQVIA
IQV
|
$19.5M |
| 4 |
Envista
NVST
|
$10.5M |
| 5 |
Guardant Health
GH
|
$10.2M |
Top Sells
| 1 |
Humana
HUM
|
$12.6M |
| 2 |
Cencora
COR
|
$9.74M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$8.98M |
| 4 |
HCA Healthcare
HCA
|
$7.19M |
| 5 |
Intuitive Surgical
ISRG
|
$6.93M |
Sector Composition
| 1 | Healthcare | 93% |
| 2 | Technology | 3.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Encompass Health
EHC
$12.3B
| $34.1M | 8.58% | 550,000 +150,000 | +38% | +$9.29M |
|
|
2
Hologic
HOLX
$14.9B
| $28.5M | 7.18% | +500,000 | New | +$28.5M |
|
|
3
Baxter International
BAX
$12.7B
| $28.4M | 7.16% | 330,000 +230,000 | +230% | +$19.8M |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $24.2M | 6.1% | 436,127 -63,873 | -13% | -$3.55M |
|
5
Charles River Laboratories
CRL
$8.04B
| $22.7M | 5.71% | 130,000 +30,000 | +30% | +$5.23M |
|
6
Boston Scientific
BSX
$156B
| $21.1M | 5.31% | 600,000 | – | – |
|
|
CTLT
7
DELISTED
CATALENT, INC.
CTLT
| $20.5M | 5.17% | 280,000 +80,000 | +40% | +$5.86M |
|
|
8
IQVIA
IQV
$32.4B
| $19.5M | 4.92% | +137,577 | New | +$19.5M |
|
9
Twist Bioscience
TWST
$1.63B
| $19M | 4.8% | 420,510 +43,470 | +12% | +$1.97M |
|
|
NVRO
10
DELISTED
NEVRO CORP.
NVRO
| $18M | 4.53% | 150,485 +10,485 | +7% | +$1.25M |
|
11
Molina Healthcare
MOH
$9.8B
| $17.8M | 4.48% | 100,000 +6,903 | +7% | +$1.23M |
|
12
Bristol-Myers Squibb
BMY
$96B
| $16.9M | 4.26% | 287,710 +37,710 | +15% | +$2.22M |
|
|
INOV
13
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $14.1M | 3.56% | 733,053 +276,402 | +61% | +$5.32M |
|
|
14
Guardant Health
GH
$8.41B
| $13.4M | 3.38% | 165,500 +125,500 | +314% | +$10.2M |
|
15
McKesson
MCK
$85.4B
| $13M | 3.28% | 85,000 +20,000 | +31% | +$3.07M |
|
|
CHNG
16
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $12.9M | 3.24% | 1,147,800 -13,913 | -1% | -$156K |
|
|
AXNX
17
DELISTED
Axonics, Inc. Common Stock
AXNX
| $12.2M | 3.07% | 347,591 +147,591 | +74% | +$5.18M |
|
|
18
Envista
NVST
$3.52B
| $10.5M | 2.66% | +500,000 | New | +$10.5M |
|
19
Inspire Medical Systems
INSP
$2.77B
| $10.1M | 2.54% | +116,054 | New | +$10.1M |
|
20
Zimmer Biomet
ZBH
$21B
| $8.36M | 2.1% | 70,000 | – | – |
|
21
Surgery Partners
SGRY
$2.91B
| $7.83M | 1.97% | +676,652 | New | +$7.83M |
|
22
Adaptive Biotechnologies
ADPT
$2.01B
| $7.26M | 1.83% | 150,000 | – | – |
|
23
Royalty Pharma
RPRX
$15.6B
| $4.86M | 1.22% | +100,000 | New | +$4.86M |
|
24
Brookdale Senior Living
BKD
$1.83B
| – | – | -1,500,000 | Closed | -$4.68M |
|
|
25
Cencora
COR
$56.5B
| – | – | -110,000 | Closed | -$9.74M |
|